The latest local and international news on nuclear medicine and radiation products.
NNSA collaborates with South African firm on groundbreaking conversion to low-enriched uranium-based molybdenum-99 production
WASHINGTON, D.C. – The U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) and South African Nuclear Energy Corporation’s NTP Radioisotopes SOC Ltd (NTP) completed conversion of their critical medical isotope molybdenum-99 (Mo-99)...read more
NTP Radioisotopes is a key international player in the nuclear technology business – with a market foot print in 50 countries. In a special report published in the Financial Mail, Group MD Tina Eboka discusses the remarkable turnaround of this state-owned company....read more
Nuclear medicine is underutilised in South Africa despite its potential to improve health outcomes and reduce medical costs, says Principal Specialist in Nuclear Medicine and Head of Nuclear Medicine at Durban’s Inkosi Albert Luthuli Central Hospital, Dr Nozipho...read more
Tina Eboka, Group MD of the NTP Group of companies, a subsidiary of the South African Nuclear Energy Corporation (Necsa), has been re-elected as vice chair of the OECD Nuclear Energy Agency High-Level Group on the Security of Supply of Medical Radioisotopes (HLG-MR)....read more
South African nuclear company NTP Radioisotopes (NTP), a subsidiary of the State-owned South African Nuclear Energy Corporation (better known as Necsa), has increased its production of, and its share in the global market for, the Molybdenum-99 (Mo-99) radioisotope,...read more